EMBC · Insider Trading
Embecta Corp. Common Stock
Every open-market purchase and sale reported by EMBC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Milton Mayo Morris | Director | Sell | −6,293 | −$36.97K |
| 2026-08-13 | Devdatt Kurdikar | President and CEO | Buy | +30,000 | +$140.94K |
| 2026-08-13 | Jacob Elguicze | SVP and CFO | Buy | +20,000 | +$93.36K |
| 2026-08-13 | Jeffrey Z Mann | Pres, Pharm Svc&Prod Mgmt, CLO | Buy | +20,000 | +$99.80K |
| 2026-08-13 | Robert J. Hombach | Director | Buy | +45,000 | +$223.85K |
| 2026-08-11 | Jean Casner | Chief Human Resources Officer | F | −1,480 | −$6.54K |
| 2026-06-02 | Anthony M. Roth | VP, Chief Accounting Officer | A | +30,000 | — |
| 2026-02-13 | Christopher R Reidy | Director | A | +22,841 | — |
| 2026-02-13 | Claire Pomeroy | Director | A | +22,841 | — |
| 2026-02-13 | Milton Mayo Morris | Director | A | +22,841 | — |
| 2026-02-13 | Robert J. Hombach | Director | A | +22,841 | — |
| 2026-02-13 | Karen Prange | Director | A | +22,841 | — |
| 2026-02-13 | Carrie L Anderson | Director | A | +22,841 | — |
| 2025-12-03 | Jeffrey Z Mann | SVP, GC, Head Corp. Dev., Secy | — | — | — |
| 2025-12-03 | Jacob Elguicze | SVP and CFO | — | — | — |
| 2025-12-01 | Devdatt Kurdikar | President and CEO | MIXED | +263,382 | −$1.62M |
| 2025-12-01 | Jacob Elguicze | SVP and CFO | MIXED | +100,831 | −$311.51K |
| 2025-12-01 | Jeffrey Z Mann | SVP, GC, Head Corp. Dev., Secy | MIXED | +84,445 | −$246.43K |
| 2025-12-01 | Anthony M. Roth | Chief Accounting Officer | MIXED | +30,936 | −$23.64K |
| 2025-12-01 | Shaun Curtis | SVP, Global Manuf./Sup. Chain | MIXED | +33,714 | −$193.33K |
| 2025-12-01 | Jean Casner | Chief Human Resources Officer | MIXED | +35,458 | −$41.80K |
| 2025-08-11 | Jean Casner | Chief Human Resources Officer | F | −916 | −$11.25K |
| 2025-05-23 | David F Melcher | Director | Buy | +10,000 | +$106.00K |
| 2025-04-08 | Jeffrey Z Mann | SVP, GC, Head Corp. Dev., Secy | F | −5,285 | −$63.42K |
| 2025-04-08 | Jacob Elguicze | SVP and CFO | F | −4,948 | −$59.38K |
| 2025-04-08 | Devdatt Kurdikar | President and CEO | F | −39,592 | −$475.10K |
| 2025-04-08 | Shaun Curtis | SVP, Global Manuf./Sup. Chain | F | −3,249 | −$38.99K |
| 2025-02-25 | David F Melcher | Director | Buy | +13,000 | +$177.65K |
| 2025-02-14 | Karen Prange | Director | A | +13,839 | — |
| 2025-02-14 | Christopher R Reidy | Director | A | +13,839 | — |
| 2025-02-14 | David Albritton | Director | A | +13,839 | — |
| 2025-02-14 | Claire Pomeroy | Director | A | +13,839 | — |
| 2025-02-14 | David F Melcher | Director | A | +17,450 | — |
| 2025-02-14 | Milton Mayo Morris | Director | MIXED | +10,739 | −$50.78K |
| 2025-02-14 | Robert J. Hombach | Director | A | +13,839 | — |
| 2025-02-14 | Carrie L Anderson | Director | A | +13,839 | — |
| 2024-12-04 | Anthony M. Roth | Chief Accounting Officer | A | +15,762 | — |
| 2024-11-29 | Devdatt Kurdikar | President and CEO | MIXED | +138,210 | −$915.48K |
| 2024-11-29 | Jeffrey Z Mann | SVP, GC, Head Corp. Dev., Secy | MIXED | +42,787 | −$149.90K |
| 2024-11-29 | Jean Casner | Chief Human Resources Officer | MIXED | +22,115 | −$23.95K |
| 2024-11-29 | Jacob Elguicze | SVP and CFO | MIXED | +51,713 | −$182.98K |
| 2024-11-29 | Shaun Curtis | SVP, Global Manuf./Sup. Chain | MIXED | +18,259 | −$108.57K |
| 2024-08-13 | Jean Casner | Chief Human Resources Officer | F | −916 | −$14.10K |
| 2024-05-14 | Jacob Elguicze | SVP and CFO | F | −1,013 | −$14.43K |
| 2024-04-08 | Devdatt Kurdikar | President and CEO | F | −4,535 | −$57.96K |
| 2024-02-13 | Devdatt Kurdikar | President and CEO | F | −17,165 | −$279.10K |
| 2024-02-12 | David F Melcher | Director | Buy | +2,000 | +$32.50K |
| 2024-02-09 | Milton Mayo Morris | Director | A | +11,455 | — |
| 2024-02-09 | Karen Prange | Director | A | +11,455 | — |
| 2024-02-09 | Claire Pomeroy | Director | A | +11,455 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Devdatt Kurdikar | President and CEO | 804,918 | $5.47M |
| Jacob Elguicze | SVP and CFO | 309,138 | $2.10M |
| Jeffrey Z Mann | Pres, Pharm Svc&Prod Mgmt, CLO | 262,915 | $1.79M |
| Robert J. Hombach | Director | 109,587 | $745.19K |
| Shaun Curtis | SVP, Global Manuf./Sup. Chain | 95,323 | $648.20K |
| David F Melcher | Director | 86,681 | $589.43K |
| Jean Casner | Chief Human Resources Officer | 85,914 | $584.22K |
| Anthony M. Roth | VP, Chief Accounting Officer | 78,833 | $536.07K |
| Christopher R Reidy | Director | 70,122 | $476.83K |
| Claire Pomeroy | Director | 66,127 | $449.66K |
| Karen Prange | Director | 64,581 | $439.15K |
| Carrie L Anderson | Director | 64,581 | $439.15K |
| Milton Mayo Morris | Director | 53,828 | $366.03K |
| David Albritton | Director | 39,743 | $270.25K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EMBC quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.